Medical News

RSS

New TAXUS Liberté Stent demonstrates superior results for treating long lesions

Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS(R) Liberté(R) Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. Three-year results from the TAXUS ATLAS Small Vessel and Long Lesion Trials continue to show significant advantages for the newer TAXUS Liberté Stent when compared to the first-generation TAXUS(R) Express(R) Stent.

23 Sep 2009

Agilent Technologies and Applied Biosystems to co-market SureSelect system

Agilent Technologies Inc. (NYSE:A) and Applied Biosystems, part of Life Technologies Corp. (NASDAQ:LIFE), today introduced the Agilent SureSelect Target Enrichment System, which is optimized for the SOLiD™ System, a next-generation advanced genomic analysis sequencing platform.

23 Sep 2009

First step to reducing smoking in America

The U.S. Food and Drug Administration announced today a ban on cigarettes with flavors characterizing fruit, candy, or clove. The ban, authorized by the new Family Smoking Prevention and Tobacco Control Act, is part of a national effort by the FDA to reduce smoking in America. Smoking is the leading preventable cause of death in America.

23 Sep 2009

Online Investor Fact Sheet available: XerTech

XerTech Inc. (OTCBB:XTCH) a leading manufacturer, seller, and distributor of cutting-edge, interactive fitness systems for the commercial fitness, sporting goods, education, and healthcare industries, announces the availability of a new online Investor Fact Sheet.

23 Sep 2009

Ambassador Nancy G. Brinker calls for a global fight against cancer

The leader of the global breast cancer movement today warned of a coming wave of cancer deaths and told global health ministers to be “fearless and united” in addressing the growing cancer crisis, particularly in developing countries.

23 Sep 2009

Top 20 pharma companies seek out new partnering opportunities at BIO-Europe 2009

In order to seek out new partnering opportunities, the top 20 big pharma companies will be in attendance on November 2–4 in Vienna, Austria for BIO-Europe 2009, the largest dedicated partnering conference in Europe.

23 Sep 2009

UBC acquires Gigamoto Technology Partners to implement risk management programs

United BioSource Corporation (UBC) today announced the acquisition of Gigamoto Technology Partners, Inc. (Gigamoto), a Pennsylvania-based software development company providing leading-edge technology solutions in support of drug safety and risk management programs for the life sciences industry.

23 Sep 2009

Nasdaq issues TLC Vision a noncompliance letter regarding minimum bid price

TLC Vision Corporation (NASDAQ: TLCV) (TSX: TLC) announced today that, on September 16, 2009, it received letters from The Nasdaq Stock Market indicating that, for the last 30 consecutive business days, the Company's common stock has not maintained a minimum value of publicly held shares of $15 million as required by Marketplace Rule 5450(b)(2)(C) or 5450(b)(3)(C) (the "MVPHS Rule") and the bid price of the Company's common stock has closed below the minimum $1.00 per share requirement for continued inclusion under Marketplace Rule 5450(a)(1) (the "Minimum Bid Price Rule").

23 Sep 2009

Statement from David Kears regarding Legislative Bill AB 1422

I would like to thank my fellow commissioners, Executive Director Kris Perry and the First 5 California staff for stepping forward with other like-minded partners to ensure the Healthy Family Program's survival in the coming year.

23 Sep 2009

Leading independent lives with help from Seniors Helping Seniors

Seniors Helping Seniors® in-home services demonstrate that with a powerful mission and strong values anything is possible. Despite the turbulent economic climate and challenges facing our nation, Seniors Helping Seniors franchise organization continues its steady growth as they gear up for their biggest fall season to date.

23 Sep 2009

Utah medical ethics expert chairs NIH review of embryonic cells

University of Utah medical ethics expert Jeffrey R. Botkin will chair a federal panel that will review scientists' requests to conduct government-funded research using embryonic stem cells left over from couples who used "test-tube fertilization" to have babies.

23 Sep 2009

Dust Alert sensor to monitor quality of air

Worried that dust from a nearby construction zone will harm your family's health? A new Tel Aviv University tool could either confirm your suspicions or better yet, set your mind at rest.

23 Sep 2009

Phase 1 extension study results of Plexxikon's PLX4032 in metastatic melanoma patients encouraging

Plexxikon Inc. today announced encouraging clinical data from a Phase 1 extension study of PLX4032 (RG7204) in metastatic melanoma patients, which expand the results announced from the initial phase of the study. PLX4032 is a novel, oral and highly selective drug that targets the BRAFV600E cancer-causing mutation that occurs in about 50 percent of melanomas and about eight percent of all solid tumors.

23 Sep 2009

Benefitfocus and USAble Life announce multi-year partnership

Benefitfocus® and USAble Life announced today a multi-year partnership through 2013 that leverages the Benefitfocus suite of solutions to transform the way group and voluntary benefits are sold, enrolled, billed and serviced.

23 Sep 2009

NIH funding helps to boost sales of DNA sequencers

Rapid increase in output from second-generation DNA sequencers has enabled new levels of productivity and new experiments. This, along with funding from the stimulus bill, has caused rapid adoption of these machines, according to healthcare market research firm Kalorama Information, helping to fuel sales of DNA sequencers to $480 million in 2008. In its report "DNA Sequencing Equipment and Services Markets, 2nd Edition," Kalorama says more changes are on the way and will drives sales growth of 19% annually through 2013.

23 Sep 2009

LTC declares a quarterly cash dividend on its Series E Cumulative Convertible Preferred Stock

LTC Properties, Inc. (NYSE:LTC) announced today that it had declared the quarterly cash dividend of $0.53125 per share on its 8.5% Series E Cumulative Convertible Preferred Stock. The dividend is payable on October 15, 2009 to stockholders of record on October 1, 2009.

23 Sep 2009

SynCardia Systems and AorTech International sign technology license agreement

On Sept. 22, SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, announced an exclusive technology licensing agreement with AorTech International plc (AIM: AOR).

23 Sep 2009

EU-U.S. trans-disciplinary research agenda for synthetic biology

The Wilson Center's Synthetic Biology project recently received two grants from the National Science Foundation. One will support a Transatlantic Exploratory Workshop on the Implications of Cutting-Edge Biotechnologies for Sustainability Science and Policy, and the other will support research on the use of on-line prediction markets to explore emerging issues in synthetic biology.

23 Sep 2009

Niti Surgical Solutions receives patent certificates for Hand CAC 30 and CAR 31 in Japan and China

NiTi Surgical Solutions, an innovative surgical device company, today announced the Japan Patent Office and the Patent Office of China have issued patent certificates that cover two of the company’s products, the Hand CAC™ 30 Compressions Anastomosis Clip applicator and CAR™ 31 Compression Anastomosis Ring.

23 Sep 2009

Technological and scientific initiatives from Helicos BioSciences Corporation

Helicos BioSciences Corporation provided updates on recent scientific findings and progress on Helicos’s technology initiatives. Speaking at the Personal Genomes conference in Cold Spring Harbor, NY, and the CHI Next Generation Sequencing conference in Providence, RI, Patrice Milos, Ph.D. Vice President and Chief Scientific Officer provided an overview of recent technological and scientific initiatives underway at Helicos.

23 Sep 2009